← Back to Clinical Trials
Recruiting NCT07354048

NCT07354048 Impact Of Thyroid Dysfunction on Liver Function Tests

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07354048
Status Recruiting
Phase —
Sponsor Sohag University
Condition Thyroid Disease
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-07-14
Primary Completion 2026-01-30

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 60 Years
Study Type OBSERVATIONAL
Interventions
Control groupPatients with hypothyroidism or hyperthyroidism that are controlled on treatmentPatients with hypothyroidism or hyperthyroidism that are not controlled on treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-07-14 with a primary completion date of 2026-01-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effect of thyroid dysfunction on liver function tests.

Eligibility Criteria

Inclusion Criteria: * All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism. * Euthyroid controls (clinically healthy control subjects were recruited from the general population with the same socio-economic status with the subjects.) Exclusion Criteria: * Patients aged \< 20 years old. * Patients With Liver Disease. * Pregnant and lactating women. * Patients with severe infections or sepsis. * Patients with Heart Disease. * Patients who on drugs that can affect liver function such as phenothiazine, phenylbutazone, methyldopa, among others.

Contact & Investigator

Central Contact

Omnia A Mohamed, Resident

✉ omnia_ahmed_post@med.sohag.edu.eg

📞 01285252564

Frequently Asked Questions

Who can join the NCT07354048 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Thyroid Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07354048 currently recruiting?

Yes, NCT07354048 is actively recruiting participants. Contact the research team at omnia_ahmed_post@med.sohag.edu.eg for enrollment information.

Where is the NCT07354048 trial being conducted?

This trial is being conducted at Sohag, Egypt.

Who is sponsoring the NCT07354048 clinical trial?

NCT07354048 is sponsored by Sohag University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology